Quarterly Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7583108

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-597,616,000 JPY
-534,728,000 JPY
Net cash provided by (used in) operating activities
-600,499,000 JPY
-531,656,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-321,000 JPY
JPY
Net cash provided by (used in) investing activities
-321,000 JPY
JPY
Cash flows from financing activities
Purchase of treasury shares
-37,000 JPY
-173,000 JPY
Net cash provided by (used in) financing activities
-37,000 JPY
119,857,000 JPY
Effect of exchange rate change on cash and cash equivalents
73,000 JPY
-709,000 JPY
Net increase (decrease) in cash and cash equivalents
-600,785,000 JPY
-412,508,000 JPY
Cash and cash equivalents
667,706,000 JPY
1,268,492,000 JPY
1,676,103,000 JPY
2,088,612,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.